Expression and Prognosis Value of the KLF Family Members in Colorectal Cancer

• Published in: Journal of oncology Vol. 2022; pp. 6571272 - 13
• Main Authors: Huang, Zhongting, He, Haibin, Qiu, Feng, Qian, Hailong
• Format: Journal Article
• Language: English
• Published: Egypt Hindawi 19.03.2022; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Apoptosis; Breast cancer; Colorectal cancer; DNA methylation; Family; Gene expression; Gene mutations; Genes; Genetic aspects; Genomes; Genomics; Lung cancer; Lymphocytes; Medical prognosis; Metastasis; Prostate cancer; Regression analysis; RNA; Software; Survival analysis
• ISSN: 1687-8450; 1687-8450; 1687-8469
• DOI: 10.1155/2022/6571272

Krüppel-like factors (KLFs) are some kind of transcriptional regulator that regulates a broad range of cellular functions and has been linked to the development of certain malignancies. KLF expression patterns and prognostic values in colorectal cancer (CRC) have, however, been investigated rarely. To investigate the differential expression, predictive value, and gene mutations of KLFs in CRC patients, we used various online analytic tools, including ONCOMINE, TCGA, cBioPortal, and the TIMER database. KLF2-6, KLF8-10, KLF12-15, and KLF17 mRNA expression levels were dramatically downregulated in CRC tissues, but KLF1, KLF7, and KLF16 mRNA expression levels were significantly elevated in CRC tissues. According to the findings of Cox regression analysis, upregulation of KLF3, KLF5, and KLF6 and downregulation of KLF15 were linked with a better prognosis in CRC. For functional enrichment, our findings revealed that KLF members are involved in a variety of cancer-related biological processes. In colon cancer and rectal cancer, KLFs were also shown to be associated with a variety of immune cells. The findings of this research reveal that KLF family members’ mRNA expression levels are possible prognostic indicators for patients with CRC.